EUR 24.3
(1.25%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 11.16 Million | 13.81 Million | 6.38 Million | 12.57 Million | 8.63 Million | 6.76 Million |
Net Income | 6.92 Million | 5.49 Million | 5.5 Million | 8.39 Million | 6.92 Million | 4.06 Million |
Depreciation & Amortization | 3.96 Million | 3.66 Million | 3.27 Million | 3.11 Million | 2.81 Million | 1.5 Million |
Deferred income taxes | 797 Thousand | 2.3 Million | 666 Thousand | -1.21 Million | -2.53 Million | 111 Thousand |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -537 Thousand | 2.01 Million | -3.27 Million | 1.94 Million | 1.05 Million | 215 Thousand |
Other non-cash items | 811 Thousand | 5.64 Million | 10.04 Million | 4.61 Million | 4.95 Million | 1.19 Million |
Investing Cash Flow | -2.64 Million | -2.68 Million | -558 Thousand | -2.48 Million | -3.7 Million | -1.11 Million |
Investments in PPE | -2.64 Million | -2.73 Million | -3.31 Million | -2.49 Million | -1.54 Million | -484 Thousand |
Acquisitions | - | 49 Thousand | 2.75 Million | 5000.00 | -2.15 Million | 70 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1000.00 | -1000.00 | -1.24 Million | -1000.00 | -1.00 | -705 Thousand |
Financing Cash Flow | -7.52 Million | -6.92 Million | -3.82 Million | -6.63 Million | -2.26 Million | -842 Thousand |
Debt repayment | -476 Thousand | -473 Thousand | -470 Thousand | -868 Thousand | -1.09 Million | -842 Thousand |
Dividends payments | -3.6 Million | -2.42 Million | -2.24 Million | -2.13 Million | -1.97 Million | - |
Common Stock Repurchased | -2.62 Million | -3.28 Million | -400 Thousand | -2.76 Million | -511 Thousand | - |
Common Stock Issuance | - | 3.75 Million | 870 Thousand | 3.63 Million | -585 Thousand | - |
Other Financing Activities | -808 Thousand | -4.5 Million | -1.57 Million | -4.5 Million | 1.89 Million | - |
Accounts receivables | 211 Thousand | 2.23 Million | 1.45 Million | 581 Thousand | -283 Thousand | 4000.00 |
Accounts payables | -893 Thousand | -314 Thousand | -4.2 Million | 1.4 Million | 1.46 Million | 868 Thousand |
Inventory | 145 Thousand | 95 Thousand | -534 Thousand | -38 Thousand | -135 Thousand | 211 Thousand |
Other working capital | -894 Thousand | - | - | - | - | -868 Thousand |
Cash at beginning of period | 24.14 Million | 19.99 Million | 17.94 Million | 14.42 Million | 11.71 Million | 6.9 Million |
Cash at end of period | 25.17 Million | 24.14 Million | 19.99 Million | 17.94 Million | 14.42 Million | 11.71 Million |
Capital Expenditure | -2.64 Million | -2.73 Million | -3.31 Million | -2.49 Million | -1.54 Million | -484 Thousand |
Effect of forex changes on cash | 44 Thousand | -53 Thousand | 42 Thousand | 74 Thousand | 44 Thousand | 3000.00 |
Net cash flow / Change in cash | 1.03 Million | 4.14 Million | 2.04 Million | 3.52 Million | 2.7 Million | 4.8 Million |
Free Cash Flow | 8.51 Million | 11.07 Million | 3.06 Million | 10.07 Million | 7.08 Million | 6.28 Million |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 463 Thousand | 6.92 Million | 5.63 Million | 1.29 Million | 4.51 Million | 5.49 Million |
Depreciation & Amortization | 1.97 Million | 3.96 Million | 1.99 Million | 1.89 Million | 1.88 Million | 3.66 Million |
Deferred income taxes | - | 797 Thousand | 797 Thousand | - | 2.3 Million | 2.3 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.55 Million | -537 Thousand | 9.34 Million | -9.88 Million | 10.55 Million | 2.01 Million |
Other non-cash items | -11.97 Million | 811 Thousand | -5 Million | 13.41 Million | -6.23 Million | 5.64 Million |
Investing Cash Flow | -2.32 Million | -2.64 Million | -1.11 Million | -1.53 Million | -1.52 Million | -2.68 Million |
Investments in PPE | -538 Thousand | -2.64 Million | -1.11 Million | -1.53 Million | -1.52 Million | -2.73 Million |
Acquisitions | -976 Thousand | - | - | - | 1000.00 | 49 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -809 Thousand | -1000.00 | -960 Thousand | -818 Thousand | -1000.00 | -1000.00 |
Financing Cash Flow | -5.14 Million | -7.52 Million | -2.02 Million | -5.49 Million | -2.1 Million | -6.92 Million |
Debt repayment | -931 Thousand | -476 Thousand | -239 Thousand | -237 Thousand | -237 Thousand | -473 Thousand |
Dividends payments | -3.71 Million | -3.6 Million | - | -3.6 Million | - | -2.42 Million |
Common Stock Repurchased | -502 Thousand | -2.62 Million | -1.35 Million | -1.27 Million | -1.46 Million | -3.28 Million |
Common Stock Issuance | - | - | - | 1.5 Million | - | 3.75 Million |
Other Financing Activities | -445 Thousand | -808 Thousand | -671 Thousand | -1000.00 | -639 Thousand | -4.5 Million |
Accounts receivables | 1.31 Million | 211 Thousand | -1.26 Million | 1.47 Million | -1.21 Million | 2.23 Million |
Accounts payables | -11.51 Million | -893 Thousand | 10.89 Million | -11.78 Million | 11.98 Million | -314 Thousand |
Inventory | 237 Thousand | 145 Thousand | -285 Thousand | 430 Thousand | -343 Thousand | 95 Thousand |
Other working capital | - | - | - | - | 127 Thousand | - |
Cash at beginning of period | 25.17 Million | 24.14 Million | 10.1 Million | 24.14 Million | 8.93 Million | 19.99 Million |
Cash at end of period | 9.67 Million | 25.17 Million | 25.17 Million | 10.1 Million | 24.14 Million | 24.14 Million |
Capital Expenditure | -538 Thousand | -2.64 Million | -1.11 Million | -1.53 Million | -1.52 Million | -2.73 Million |
Effect of forex changes on cash | -59 Thousand | 44 Thousand | 91 Thousand | -47 Thousand | -24 Thousand | -53 Thousand |
Net cash flow / Change in cash | -15.5 Million | 1.03 Million | 15.07 Million | -14.03 Million | 15.21 Million | 4.14 Million |
Free Cash Flow | -8.51 Million | 8.51 Million | 17.01 Million | -8.5 Million | 18.16 Million | 11.07 Million |
SANDESH
PTTWF
MLCMB
002299
INCR
PVRINOX